AU5948286A - Anthranilic acid derivatives - Google Patents

Anthranilic acid derivatives

Info

Publication number
AU5948286A
AU5948286A AU59482/86A AU5948286A AU5948286A AU 5948286 A AU5948286 A AU 5948286A AU 59482/86 A AU59482/86 A AU 59482/86A AU 5948286 A AU5948286 A AU 5948286A AU 5948286 A AU5948286 A AU 5948286A
Authority
AU
Australia
Prior art keywords
acid derivatives
anthranilic acid
anthranilic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59482/86A
Inventor
Dieter Duwel
Heinz Loewe
Gerhard Lohaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU5948286A publication Critical patent/AU5948286A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59482/86A 1985-07-03 1986-07-02 Anthranilic acid derivatives Abandoned AU5948286A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3523705 1985-07-03
DE19853523705 DE3523705A1 (en) 1985-07-03 1985-07-03 MEDICINAL PRODUCTS AND THE USE THEREOF

Publications (1)

Publication Number Publication Date
AU5948286A true AU5948286A (en) 1987-01-08

Family

ID=6274794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59482/86A Abandoned AU5948286A (en) 1985-07-03 1986-07-02 Anthranilic acid derivatives

Country Status (11)

Country Link
EP (1) EP0216028A2 (en)
JP (1) JPS6210057A (en)
AU (1) AU5948286A (en)
DD (1) DD248056A5 (en)
DE (1) DE3523705A1 (en)
DK (1) DK314686A (en)
GR (1) GR861712B (en)
HU (1) HUT44483A (en)
PT (1) PT82901B (en)
ZA (1) ZA864915B (en)
ZM (1) ZM4886A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397798A (en) * 1990-12-18 1995-03-14 Eli Lilly And Company Benzamide and sulfonamide hypoglycemic agents
CN106660961A (en) * 2014-08-29 2017-05-10 瑞士诺华动物保健有限公司 Novel sulfonylaminobenzamide compounds as anthelmintics

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0420804A3 (en) * 1989-09-26 1991-11-27 Ciba-Geigy Ag Anthelmintic compounds
EP0420805A3 (en) * 1989-09-26 1991-10-16 Ciba-Geigy Ag Anthelmintic compounds
GB9511694D0 (en) * 1995-06-09 1995-08-02 Fujisawa Pharmaceutical Co Benzamide derivatives
DE19830431A1 (en) 1998-07-08 2000-01-13 Hoechst Marion Roussel De Gmbh Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators
EP1317260A2 (en) * 2000-08-30 2003-06-11 Signature Bioscience, Inc. Methods for treating tumors using sulfonyl compounds
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
BRPI0515917A (en) * 2004-09-23 2008-08-12 Schering Plough Ltd control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
JPWO2006077901A1 (en) * 2005-01-20 2008-06-19 塩野義製薬株式会社 CTGF expression inhibitor
US8067638B2 (en) 2005-06-21 2011-11-29 Mitsui Chemicals, Inc. Amide derivative and insecticide containing the same
WO2019232384A1 (en) 2018-06-01 2019-12-05 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397798A (en) * 1990-12-18 1995-03-14 Eli Lilly And Company Benzamide and sulfonamide hypoglycemic agents
CN106660961A (en) * 2014-08-29 2017-05-10 瑞士诺华动物保健有限公司 Novel sulfonylaminobenzamide compounds as anthelmintics
CN106660961B (en) * 2014-08-29 2020-05-05 瑞士伊兰科动物保健有限公司 Sulfonylaminobenzamide compounds as anthelmintics

Also Published As

Publication number Publication date
EP0216028A2 (en) 1987-04-01
ZA864915B (en) 1987-02-25
GR861712B (en) 1986-10-31
DK314686A (en) 1987-01-04
HUT44483A (en) 1988-03-28
DK314686D0 (en) 1986-07-02
JPS6210057A (en) 1987-01-19
PT82901B (en) 1989-01-30
DD248056A5 (en) 1987-07-29
ZM4886A1 (en) 1987-03-27
PT82901A (en) 1986-08-01
DE3523705A1 (en) 1987-01-08

Similar Documents

Publication Publication Date Title
AU572402B2 (en) 25-avermectin derivatives
GB8614616D0 (en) Thiazolidinecarboxylic acid derivatives
AU8292687A (en) Thiol-carboxylic acid derivatives
AU8297787A (en) 1h-imadazole-5-carboxylic acid derivatives
AU1415188A (en) New ribofuranuronic acid derivatives
AU4282985A (en) Quinolinecarboxylic acid derivatives
AU576685B2 (en) Chromoglycic acid derivatives
AU587108B2 (en) Imidazolecarboxylic acid derivatives
AU5948286A (en) Anthranilic acid derivatives
AU6169186A (en) Amino acid derivatives
AU583909B2 (en) Substituted 2,3,4,9-Tetrahydro-1H-Carbazole-1-Acetic acid derivatives
AU5638686A (en) Cyclohexylamidazole derivatives
AU5088485A (en) 1-phenylimidazole-5-carboxylic acid derivatives
AU6603586A (en) Imidazopyridazinealkenoic acid amides
AU5349386A (en) Barbituric acid derivatives
AU562773B2 (en) Tetrahydroimidazoquinazolinone derivatives
AU5555586A (en) Acetic acid derivatives containing phosphorus
AU581066B2 (en) Cyanoalkanimidamidophenylpyridazinone derivatives
AU5511986A (en) 2-arylbenzothiazine derivatives
AU8314987A (en) 1-methyl-1h-imidazole-5-carboxylic acid derivatives
GB8509086D0 (en) Dihydronicotinic acid derivatives
AU5899386A (en) 1,4-dihydro-nicotinic acid derivatives
AU5984386A (en) 3-chloro-3-cephem-4-carboxylic acid derivatives
AU577712B2 (en) Quinolonecarboxylic acid derivatives
AU576877B2 (en) Apovincaminic acid derivatives